跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
硫酸吗啡缓释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Morphine Sulphate Sustained-release Tablets
Approved
化学药品
Morphine Sulphate Sustained-release Tablets
NAPP PHARMACEUTICALS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Aug 6, 2024
Approval ID
8b3Gyrhd0NU
Company
NAPP PHARMACEUTICALS LIMITED
Type
化学药品
Approval Details
Approval Id
8b3Gyrhd0NU
Approval Number
国药准字HJ20130904
Generic Name
硫酸吗啡缓释片
Generic Name En
Morphine Sulphate Sustained-release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
60mg
Reg Date
2024-08-06
Expired Date
2029-06-13
Company Name
NAPP PHARMACEUTICALS LIMITED
Production Company Name
BARD PHARMACEUTICALS LIMITED
Company Detail Path
/organization/napp-pharmaceuticals-limited
Production Company Detail Path
/organization/bard-pharmaceuticals-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 6, 2024
Approval ID
8b3Gyrhd0NU
Type
化学药品
Back to NMPA Approvals
